Cancer patients get extended access to experimental drug after showing benefit
NCT ID NCT04887870
Summary
This study allowed patients with advanced cancers who were already benefiting from sitravatinib in a previous trial to continue receiving the drug. It monitored the safety and side effects of continued treatment with sitravatinib, either alone or combined with other cancer therapies. The goal was to provide continued access while gathering more safety data for patients who were responding well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Local Institution - 516-014-001
Austin, Texas, 78758, United States
-
Local Institution - 516-014-002
Boston, Massachusetts, 02215, United States
-
Local Institution - 516-014-004
Columbus, Ohio, 43210, United States
-
Local Institution - 516-014-005
Minneapolis, Minnesota, 55455, United States
-
Local Institution - 516-014-011
Albany, New York, 12208, United States
-
Local Institution - 516-014-013
Houston, Texas, 77030, United States
-
Local Institution - 516-014-029
Goshen, Indiana, 46526, United States
-
Memorial Sloan Kettering Cancer Center - Arnold and Marie Schwartz Cancer Research Building
New York, New York, 10065, United States
-
NEXT Virginia
Fairfax, Virginia, 22031, United States
-
Rocky Mountain Cancer Centers - Littleton
Littleton, Colorado, 80218, United States
-
USOR - Texas Oncology Northeast Texas - Denison
Denison, Texas, 75020, United States
-
Urology Cancer Center and GU Research Network
Omaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.